Purchase Order 75F40120P00419

The National Institutes of Health's National Human Genome Research Institute awarded a $697,695 firm fixed price purchase order to Olink Proteomics AB of Uppsala, Sweden. The one-year contract calls for Olink to measure the proteomic profiles of 1,000 plasma samples across 3,072 proteins using its proprietary Olink Explore 3072 technology. Performance will take place at Olink's facilities in Uppsala and Boston. There was no set-aside designation, as the sole-source award was made directly to...

The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $16,514 purchase order to Arraystar Inc. to provide exosome miRNA profiling and sequencing services. The firm fixed price contract has a period of performance from September 19, 2023 through April 25, 2024 and will be performed in Silver Spring, Maryland. Arraystar will deliver the requested exosome profiling and sequencing services to support HHS FDA programs. No subcontractors or set aside designations...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $15,000 purchase order to Biognosys AG of Switzerland to provide proteome profiling services for patients with central conducting lymphatic anomaly. Under this firm fixed price contract, Biognosys will utilize its expertise in proteomics to analyze protein expression patterns in patient samples over the one year period of performance. As the prime contractor, Biognosys will leverage its...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for...

This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...

The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $93,799.90 firm-fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., to provide services for a study on the proteomic effects of different extreme metabolic states. The contract does not have a set-aside designation. The original solicitation was a sources sought notice for small businesses to provide services to study the...

The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...

The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...

This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Applied Biomics, Inc., a self-certified small disadvantaged business. The $24,420.00 contract is for cell surface proteomics analysis and secretome profiling of human induced pluripotent stem cell (iPSC)-derived astrocytes, with a period of performance from September 9, 2020 to September 10, 2021....